Company · CIK 0001660334 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Verrica Pharmaceuticals Inc. · VRCA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 PForm 4 → | Aug 18, 5:00 pm EDT | John J. KirbyInterim CFO | 5,000 | $4.93 | $24,650 | 23,962 | +26.4% | |
| Aug 17, 2026 PForm 4 → | Aug 18, 5:00 pm EDT | David ZawitzChief Operating Officer | 6,000 | $4.98 | $29,880 | 27,000 | +28.6% | |
| Aug 17, 2026 PForm 4 → | Aug 18, 5:00 pm EDT | Noah L. RosenbergCMO | 6,230 | $4.91 | $30,610 | 8,587 | +264% | |
| Aug 14, 2026 PForm 4 → | Aug 18, 5:00 pm EDT | Jayson RiegerCEO and President, Director | 25,000 | $5.03 | $125,750 | 207,593 | +13.7% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.